ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesC74.01

C74.01

Billable

Malignant neoplasm of cortex of right adrenal gland

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 C74.01 is a billable code used to indicate a diagnosis of malignant neoplasm of cortex of right adrenal gland.

Key Diagnostic Point:

C74.01 refers to a malignant neoplasm originating in the cortex of the right adrenal gland, which is responsible for producing hormones such as cortisol, aldosterone, and androgens. These tumors can disrupt normal hormone production, leading to various endocrine disorders. Symptoms may include hypertension, weight gain, and abnormal glucose metabolism due to excess cortisol (Cushing's syndrome) or other hormonal imbalances. Diagnosis typically involves imaging studies such as CT or MRI scans, followed by biopsy to confirm malignancy. Treatment often requires surgical intervention, such as adrenalectomy, and may be followed by chemotherapy or radiation therapy depending on the tumor's characteristics. The prognosis varies based on tumor size, stage, and response to treatment, making early detection and accurate coding critical for effective management and reimbursement.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between benign and malignant adrenal tumors
  • Understanding the implications of hormone secretion on patient symptoms
  • Navigating the need for imaging and biopsy documentation
  • Recognizing the potential for metastasis from other primary cancers

Audit Risk Factors

  • Inadequate documentation of malignancy confirmation
  • Failure to document hormone-related symptoms
  • Lack of imaging study reports
  • Misclassification of tumor type

Specialty Focus

Medical Specialties

Endocrinology

Documentation Requirements

Detailed hormone level assessments, imaging studies, and biopsy results.

Common Clinical Scenarios

Patients presenting with symptoms of Cushing's syndrome or adrenal insufficiency.

Billing Considerations

Ensure documentation reflects the impact of the tumor on hormone levels and related symptoms.

Oncology

Documentation Requirements

Pathology reports confirming malignancy, treatment plans, and follow-up care.

Common Clinical Scenarios

Patients undergoing adrenalectomy or chemotherapy for adrenal cancer.

Billing Considerations

Accurate staging and grading of the tumor are essential for coding and treatment planning.

Coding Guidelines

Inclusion Criteria

Use C74.01 When
  • Follow the official ICD
  • CM coding guidelines, ensuring accurate documentation of the malignancy and any associated conditions
  • Include details on imaging and biopsy results to support the diagnosis

Exclusion Criteria

Do NOT use C74.01 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

15830CPT Code

Adrenalectomy, open

Clinical Scenario

Performed for malignant adrenal tumor.

Documentation Requirements

Operative report detailing the procedure and findings.

Specialty Considerations

Ensure the procedure is linked to the diagnosis of C74.01.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of adrenal tumors, improving the accuracy of diagnoses and treatment plans. C74.01 provides a clear distinction between malignant and benign conditions, which is crucial for treatment and reimbursement.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of adrenal tumors, improving the accuracy of diagnoses and treatment plans. C74.01 provides a clear distinction between malignant and benign conditions, which is crucial for treatment and reimbursement.

Reimbursement & Billing Impact

reimbursement.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the significance of coding C74.01 accurately?

Accurate coding of C74.01 is crucial for proper treatment planning, reimbursement, and tracking of cancer statistics. It ensures that patients receive appropriate care based on their specific diagnosis.